COVID-19 changed the healthcare industry in 2020 after the transition to digital technologies as the primary source to maintain and build patient relationships. While some health care stocks were booming, there were others that had to seek partnerships to ride the pandemic wave and survive. Market researchers and analysts are releasing new data, trends, and forecasts in various studies of the health sectors for investors to make decisions.
Livongo Health, Inc., JingKang Biotechnology, and Zhejiang Garden are a few companies that analysts and research professionals are observing in the health industry. The most recent, Livongo stock forecast, is $65, with an average target price of $119.57. That represents a negative upside from the last price set at $139.77. Fifteen Wall Street analysts, including Citigroup, Morgan Stanley, and Goldman Sachs Group, recommended investors to buy or hold Livongo’s stock shares.
Citigroup gave the stock a price target at $170 in twelve months from now, and SVB Leerink forecasts the price at $65. Livongo Health is an example of a company in the healthcare industry helping people and impacting health stocks. The corporation is a leading provider of integrated solutions to utilize its technology and promote health behavioral change using real-time data that supports medical devices and provides insights.
Livongo offers products for diabetes, prediabetes, weight management, behavioral health, and hypertension. A reason an investor may want to research the stock is because of the name change from EosHealth to Livongo Health, Inc. in 2014. You need to know this kind of information before you decide to invest, especially if there were a merger for expansion and growth. Companies with growth opportunities are attractive investments for investors needing to build their portfolios.
New Technology Developments in the Healthcare Industry
KD Market Insights released a study on the latest technology developments in the cholesterol market based on animal brain source. Investors should the report to gain knowledge of the market’s trends, technical systems, recent technologies, and alternative methods. It will help to understand the present market and provide a global outlook in Canada, United States, Europe, Africa, Middle East, and other regions.
Researchers studied the strategies applied by top healthcare companies, such as Zhejiang Garden and JingKang Biotechnology. The thorough report can benefit investors seeking opportunities in the cholesterol market and to learn the ups and downs of booming stocks in the cholesterol market. You will receive insight, the latest research, challenges the cholesterol sector faces, and international expectations for future market research expansion.
Challenges the Healthcare Industry is Facing in 2021
- The Transition of Clinical Trials
- Implementing Digital Technologies for Patients Relationships
- Uncertainty in Predictions for 2021
- Restructure of Health Care Portfolios for Growth
- Internal Organizational Resizing After the Telehealth Boom
- Improving Supply Chains for Long-Term Healthcare
Near the end of December 2020, HRI revealed in a study the challenges the healthcare industry will face in 2021. Over 2,900 U.S. consumers and executives in the healthcare provider, health plan, life sciences, and pharmaceutical industry sectors participated in the research study last year. Clinical trials are transforming the world into a permanent prediction. COVID-19 caused sponsors, patients, and research organizations needing a change after observing the advantages of a more decentralized theory.
Digital technologies became the focus since the pandemic. Consumers are relying on this technology that is effective for doctors and patients. Before COVID-19, doctors needed advanced technologies to handle their administrative tasks in the workplace.
The healthcare industry needs a prediction system that provides insight into market uncertainty. It will help companies prepare better for fluctuations in the economy, the behavior of consumers, and the insurance market. A system for predictions is helpful for investors to consider when monitoring their healthcare stocks and deciding to buy, sell, or hold securities.
From 2020 to today, virtual visits are on the rise, especially in mental health, family care, gynecology, and pediatrics. Technology plays an important role in the increase. Life science and health provider executives responded in the study that they need an overall improvement of their supply chains with better transparency.
As technologies continue to strengthen the healthcare industry, they will influence health stocks. Research studies are revealing permanent changes in the healthcare industry for growth and global expansion.